Welcome to Pam's Personal Page

Climb. Conquer. Cure.
March 24th, 2024
Hello Friends and Family! I’m excited to share that I will be participating in Big Climb Seattle again this year. With your support, this will be my 13th year actively contributing to making a significant impact in the ongoing fight against blood cancers.
Why am I doing this again? Simple answer - there isn't a cure...yet!
I climb in honor of family, friends and all those bravely facing the challenges of a cancer battle. I climb with the aim of raising funds to support the mission of the Leukemia and Lymphoma Society, facilitating ongoing research, offering support to patients, and ultimately working towards finding a cure. The discovery of a cure for blood cancers may help pave the way for finding a cure for all types of cancers.
What is the Big Climb?
The Big Climb is a stairclimb up the Columbia Center - the tallest skyscraper in downtown Seattle. There are 69 floors of stairs, 1311 steps, and 788 feet of vertical elevation. Although it will be challenging, it pales in comparison to what blood cancer patients go through. All proceeds benefit The Leukemia & Lymphoma Society.
Who is The Leukemia & Lymphoma Society?
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The mission of LLS is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
Every day, more than 347 LLS sponsored researchers come closer to the goal of finding a cure for leukemia and related blood cancers. Locally, LLS funds 10 researchers at the Fred Hutchinson Cancer Research Center and University of Washington Medical Center. Your support and commitment to the mission of LLS enables us to continue this important work of saving lives and aids us in our ability to reach patients in our community.
Thank you for your time and I hope that you will consider donating to this cause!


If you think this page contains objectionable content, please Click Here